CAS: 1342276-76-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea REF: AN-AG009W9UCAS: 1342276-76-9 | 99% | 152.00 €~616.00 € | Thu 09 May 24 |
 | RKI1313 REF: TM-T2011CAS: 1342276-76-9 | 99.06% | 230.00 €~2,233.00 € | Thu 16 May 24 |
 | RKI-1313 REF: 3D-SDC27676CAS: 1342276-76-9 | Min. 95% | To inquire | Thu 20 Jun 24 |
1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea
CAS:1342276-76-9
Formula:
C17H16N4O2S
Purity:
99%
Molecular weight:
340.3995
Ref: AN-AG009W9U
| 5mg | 152.00 € | |
| 25mg | 616.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
RKI1313
CAS:1342276-76-9
RKI1313 (RKI-1313) was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, …
Formula:
C17H16N4O2S
Purity:
99.06%
Color and Shape:
Solid
Molecular weight:
340.4
Ref: TM-T2011
| 1mg | 230.00 € | |
| 2mg | 342.00 € | |
| 5mg | 573.00 € | |
| 10mg | 817.00 € | |
| 25mg | 1,234.00 € | |
| 50mg | 1,672.00 € | |
| 100mg | 2,233.00 € | |
| 1ml*10 (DMSO) | 557.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
RKI-1313
CAS:1342276-76-9
RKI-1313 is an analog of RKI-1447 that is more potent as an inhibitor of ROCK1 …
Formula:
C17H16N4O2S
Purity:
Min. 95%
Molecular weight:
340.4 g/mol
Ref: 3D-SDC27676
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
